or Try an Advanced Search...

    Technical Analysis for UNCY - Unicycive Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 0.50 -1.85% -0.01
    UNCY closed up 5.03 percent on Wednesday, November 20, 2024, on approximately normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Flat
    Historical UNCY trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish -1.85%
    Wide Bands Range Expansion -1.85%
    Calm After Storm Range Contraction 3.09%
    NR7 Range Contraction 3.09%
    NR7-2 Range Contraction 3.09%
    Wide Bands Range Expansion 3.09%
    Calm After Storm Range Contraction 9.87%
    NR7 Range Contraction 9.87%
    NR7-2 Range Contraction 9.87%
    Wide Bands Range Expansion 9.87%
    Older End-of-Day Signals for UNCY ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 2 hours ago
    Down 1% about 2 hours ago
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    Rose Above 20 DMA about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    UNCY Chart by TradingView
    Basic chart:

    Profile

    Unicycive is a biotechnology company developing novel treatment for kidney diseases. Unicycive's lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent protected new chemical entity in late preclinical development for the treatment of acute kidney injury
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity

    Is UNCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 Unicycive NDA for hyperphosphatemia asset accepted by FDA
    Nov 11 Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
    Oct 28 Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
    Oct 16 Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024
    Oct 16 Results of Phase I trial shed positive light on UNI-494 for acute kidney injury
    Oct 9 Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
    Sep 20 Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    Sep 16 Life Sciences Virtual Investor Forum Agenda Announced for September 19th
    Sep 16 Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024
    Sep 5 Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    See more UNCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.818
    52 Week Low 0.202
    Average Volume 1,625,396
    200-Day Moving Average 0.78
    50-Day Moving Average 0.44
    20-Day Moving Average 0.49
    10-Day Moving Average 0.50
    Average True Range 0.05
    RSI (14) 55.75
    ADX 18.36
    +DI 25.49
    -DI 18.20
    Chandelier Exit (Long, 3 ATRs) 0.45
    Chandelier Exit (Short, 3 ATRs) 0.56
    Upper Bollinger Bands 0.58
    Lower Bollinger Band 0.41
    Percent B (%b) 0.6
    BandWidth 34.65
    MACD Line 0.01
    MACD Signal Line 0.02
    MACD Histogram -0.0063
    Fundamentals Value
    Market Cap 17.7 Million
    Num Shares 34.8 Million
    EPS -1.47
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 57.15
    Price-to-Book 11.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.62
    Resistance 3 (R3) 0.62 0.58 0.60
    Resistance 2 (R2) 0.58 0.56 0.58 0.60
    Resistance 1 (R1) 0.55 0.54 0.57 0.55 0.59
    Pivot Point 0.51 0.51 0.52 0.51 0.51
    Support 1 (S1) 0.47 0.48 0.49 0.47 0.43
    Support 2 (S2) 0.43 0.46 0.43 0.42
    Support 3 (S3) 0.40 0.43 0.42
    Support 4 (S4) 0.40